As mitochondrial function must be critically involved in the genetic forms of PD associated with mitochondrial genes, and the (epi-) genetic and histopathological evidence pointing towards α-synuclein, bolstering of mitochondria and targeting alpha-synuclein are natural targets. Here, SNCA is linked to Parkinson disease.